Norden Group LLC Acquires 16,490 Shares of Humana Inc. (NYSE:HUM)

Norden Group LLC lifted its position in shares of Humana Inc. (NYSE:HUM) by 3,471.6% in the 1st quarter, Holdings Channel.com reports. The fund owned 16,965 shares of the insurance provider’s stock after buying an additional 16,490 shares during the quarter. Norden Group LLC’s holdings in Humana were worth $5,882,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in HUM. Rakuten Securities Inc. bought a new stake in shares of Humana during the fourth quarter valued at approximately $25,000. Gradient Investments LLC increased its position in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 40 shares in the last quarter. Cetera Trust Company N.A bought a new stake in shares of Humana during the fourth quarter valued at approximately $28,000. Private Wealth Management Group LLC bought a new stake in shares of Humana during the fourth quarter valued at approximately $32,000. Finally, Carolinas Wealth Consulting LLC increased its position in shares of Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after acquiring an additional 74 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Trading Down 3.2 %

Shares of Humana stock opened at $362.85 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company’s fifty day simple moving average is $346.62 and its 200-day simple moving average is $350.12. The stock has a market capitalization of $43.72 billion, a PE ratio of 22.59, a P/E/G ratio of 2.10 and a beta of 0.51.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the previous year, the company earned $9.38 EPS. Humana’s revenue for the quarter was up 10.7% on a year-over-year basis. As a group, equities analysts anticipate that Humana Inc. will post 16.27 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is 22.04%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Wells Fargo & Company reduced their price target on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $360.00 target price on shares of Humana in a research report on Wednesday, June 12th. Raymond James assumed coverage on shares of Humana in a research report on Friday, March 22nd. They issued a “market perform” rating for the company. Oppenheimer cut their target price on shares of Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Finally, Bank of America lifted their target price on shares of Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research report on Monday, May 20th. Fourteen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $409.55.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.